Company Livzon Pharmaceutical Group Inc.

Equities

000513

CNE0000002Y8

Pharmaceuticals

End-of-day quote Shenzhen S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
37.55 CNY -0.08% Intraday chart for Livzon Pharmaceutical Group Inc. -1.47% +7.26%

Business Summary

LIVZON PHARMACEUTICAL GROUP INC. is a China based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products include western medicine preparation such as gastrointestinal drugs, cardiovascular drugs and antimicrobial drugs and gonadotrophin drugs, Chinese medicine preparation, active pharmaceutical ingredient and intermediates, diagnostic reagents and equipments. The Company distributes its products in the domestic market and to overseas markets.

Number of employees: 9,005

Sales per Business

CNY in Million2021Weight2022Weight Delta
Chemical
55.4 %
7,224 59.9 % 7,000 55.4 % -3.11%
APIs and Intermediates
24.8 %
2,909 24.1 % 3,138 24.8 % +7.89%
Chinese Medicine Preparation
9.9 %
1,071 8.9 % 1,254 9.9 % +17.07%
Diagnostic Reagents and Equipment
5.7 %
724 6.0 % 724 5.7 % -0.06%
Biological
3.2 %
- - 408 3.2 % -
Other Business
0.3 %
53 0.4 % 42 0.3 % -21.16%
Sales Materials
0.3 %
46 0.4 % 40 0.3 % -11.62%
Processing
0.1 %
5 0.0 % 9 0.1 % +70.82%
Power Supply
0.1 %
8 0.1 % 8 0.1 % +0.36%
Rental
0.1 %
5 0.0 % 7 0.1 % +49.48%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
87.5 %
10,389 87.1 % 10,959 87.5 % +5.48%
Overseas
12.5 %
1,539 12.9 % 1,565 12.5 % +1.72%

Managers

Managers TitleAgeSince
President 55 18-07-16
Director of Finance/CFO 56 93-03-31
Chairman 59 00-12-31
Chairman 62 01-12-31
Director/Board Member 61 07-02-28
Director/Board Member 60 84-12-31
Investor Relations Contact - -
Corporate Officer/Principal 57 18-10-24
Corporate Officer/Principal 58 96-12-31
Corporate Secretary 41 11-07-31

Members of the board

Members of the board TitleAgeSince
Chairman 62 01-12-31
Director/Board Member 53 07-03-31
Chairman 59 00-12-31
Director/Board Member 60 84-12-31
Director/Board Member 61 07-02-28
Corporate Officer/Principal 58 96-12-31
Director/Board Member 49 15-12-28
President 55 18-07-16
Director/Board Member 48 21-07-28
Director/Board Member 53 19-10-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 309,831,217 0 0 37.91 %
Stock B 1 628,247,779 355,635,814 ( 56.61 %) 11,614,548 ( 1.849 %)

Shareholders

NameEquities%Valuation
163,364,672 52.73 % 572 M ¥
UBS Asset Management (Hong Kong) Ltd.
2.417 %
7,487,622 2.417 % 26 M ¥
eQ Varainhoito Oy
0.5648 %
1,750,000 0.5648 % 6 M ¥
Nordea Investment Management AB
0.4172 %
1,292,750 0.4172 % 5 M ¥
Bosera Asset Management Co., Ltd.
0.3899 %
1,207,900 0.3899 % 4 M ¥
State Street Global Advisors Ltd.
0.1804 %
558,985 0.1804 % 2 M ¥
HSBC Jintrust Fund Management Co. Ltd.
0.1393 %
431,600 0.1393 % 2 M ¥
Robeco Hong Kong Ltd.
0.1062 %
328,900 0.1062 % 1 M ¥
RAM Active Investments SA
0.0514 %
159,154 0.0514 % 557 023 ¥
Guliver Anlageberatung GmbH
0.0509 %
157,600 0.0509 % 551 584 ¥
NameEquities%Valuation
255,513,953 42.20 % 1 367 M ¥
Penghua Fund Management Co., Ltd.
1.252 %
7,578,135 1.252 % 41 M ¥
GF Fund Management Co., Ltd.
1.222 %
7,401,479 1.222 % 40 M ¥
Huatai-PineBridge Fund Management Co., Ltd.
1.105 %
6,690,097 1.105 % 36 M ¥
5,829,048 0.9627 % 31 M ¥
China Southern Asset Management Co., Ltd.
0.7555 %
4,574,325 0.7555 % 24 M ¥
Yinhua Fund Management Co., Ltd.
0.5330 %
3,226,992 0.5330 % 17 M ¥
China Asset Management Co., Ltd.
0.4878 %
2,953,231 0.4878 % 16 M ¥
China Fund Management Co., Ltd.
0.4804 %
2,908,700 0.4804 % 16 M ¥
Guotai Asset Management Co., Ltd.
0.4687 %
2,837,970 0.4687 % 15 M ¥

Holdings

NameEquities%Valuation
5,829,048 0.96% 31,190,361 $

Company contact information

Livzon Pharmaceutical Group, Inc.

Headquarters Building 38 Chuangye North Road

519090, Zhuhai

+86 75 6813 5888

http://www.livzon.com.cn
address Livzon Pharmaceutical Group Inc.(000513)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
37.55 CNY
Average target price
39.92 CNY
Spread / Average Target
+6.30%
Consensus